CN1053810C - Compound capsule for fever release pain stop and anti-inflammation - Google Patents
Compound capsule for fever release pain stop and anti-inflammation Download PDFInfo
- Publication number
- CN1053810C CN1053810C CN94104518A CN94104518A CN1053810C CN 1053810 C CN1053810 C CN 1053810C CN 94104518 A CN94104518 A CN 94104518A CN 94104518 A CN94104518 A CN 94104518A CN 1053810 C CN1053810 C CN 1053810C
- Authority
- CN
- China
- Prior art keywords
- fever
- inflammation
- treatment
- aspirin
- present
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
The present invention relates to a formula for a compound antipyretic, acesodyne and anti-inflammatory capsule which is mainly used for the treatment of cold and fever, the assistant treatment of the fever removal of inflammatory diseases, and the treatment of rheumatism, rheumatoid disease and shoulder periarthritis. The compound antipyretic, acesodyne and anti-inflammatory capsule can also be used for the fever removing treatment of a patient who suffers from aspirin allergy and has the past medical history of Reye syndromes.
Description
The present invention relates to the capsular oral medicine of a kind of fever release pain stop and anti-inflammation powder medicine.
Compound preparations that adopt in existing fever release pain stop and anti-inflammation class medicine at present more,, antondin clear as the APC flu, these oral drugs are not obvious for the effect of bringing down a fever of hyperpyrexia disease, and very little to the effect of superelevation burning, and it is also bigger that poison is paid effect.
The objective of the invention is: provide a kind of fill a prescription simple, cost is low, draw materials can move back easily hyperpyrexia and even superelevation burnings, therapeutic index height, therapeutic domain wide, pay and act on little oral medicine.
Prescription of the present invention is: aspirin, caffeine, acetaminophen, Moroxydine, meticorten, vitamin B
1, the real mixture that belongs to each raw material of finished product.
Zoopery of the present invention (grey rabbit) result: least effective dose (LED) 6mg/kg, dosage is 24mg/kgED when reaching ceiling effect
99＜LD
1ED50=10.2mg/kgLD
50=1000mg/kg therapeutic index 98, the present invention is used for cat fever oral 18mg/kg in the time of 38.5 ℃ can remove symptom in 60 minutes, can consolidate curative effect oral 2 times/day, be used for the oral 18mg/kg of hyperpyrexia patient, 2.5 hour can bring down a fever to 37.5-38 ℃, superelevation is burnt the oral 24mg/kg of patient, 2.5 can fall back on 39 °-39.5 ℃ in hour, and being burnt other oral medicines, superelevation can not bring down a fever rapidly, the consumption of aspirin is less than the consumption of aspirin among the APC among the present invention, and the present invention is again a powder, oral after very fast under one's belt uniform distribution, and the tablet febrifuge to be local contact position drug level high and produce than strong stimulation, the present invention plays a role fast, and reducing fast stimulates, so treat when having a fever dispensing littler than APC to the injury of gastric mucosa, the present invention has aspirin and meticorten compatibility, utilize proteic metathesis in the blood, and strengthen the antiinflammatory refrigeration function of meticorten, the present invention utilizes the hyperhidrosis of Moroxydine, broad-spectrum disease resistance toxic action and play and move back hyperpyrexia is fast used vitamin B
1Replenish the B that occurs because of hyperpyrexia
1The collapse that lacks, oral adult is 0.9g/ time during the treatment scapulohumeral periarthritis, can reach complete analgesic effect for 2 times/day, the content of acetaminophen is littler and do not have and poison to take place than content among the APC in the present invention, meticorten content is littler with meticorten treatment rheumatism consumption than single among the present invention, so can be used for normal phase treatment rheumatism and rheumatoid disease, take the unlikely generation Reye syndrome of 6-12mg/kg of the present invention to aspirin allergy with when once having the patient of aspirin defective medical history to be used for hyperpyrexia.
Processing technology of the present invention is: the room temperature sterile working, the raw material powder is pressed aspirin, caffeine, acetaminophen, meticorten, Moroxydine, vitamin B
1Be 128: 55: 17 by weight: fully mix encapsulated at 4: 55: 30.
Claims (1)
- A kind of compound capsule for fever release pain stop and anti-inflammation compositions, wherein powder has the composition of aspirin, acetaminophen, caffeine, the characteristics of compound capsule for fever release pain stop and anti-inflammation of the present invention are: pine and have the Moroxydine treatment heavy cold of diaphoresis, broad-spectrum disease resistance toxic action intentinonally on the basis of original aspirin, acetaminophen, caffeine, have a high fever, add vitamin B 1Treatment is because of hyperpyrexia and the collapse of perspiring and causing, aspirin, acetaminophen, caffeine, meticorten, Moroxydine, vitamin B in the compositions 1Weight ratio be 128: 55: 17: 4: 55: 30.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN94104518A CN1053810C (en) | 1994-04-27 | 1994-04-27 | Compound capsule for fever release pain stop and anti-inflammation |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN94104518A CN1053810C (en) | 1994-04-27 | 1994-04-27 | Compound capsule for fever release pain stop and anti-inflammation |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN1110914A CN1110914A (en) | 1995-11-01 |
| CN1053810C true CN1053810C (en) | 2000-06-28 |
Family
ID=5031637
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN94104518A Expired - Fee Related CN1053810C (en) | 1994-04-27 | 1994-04-27 | Compound capsule for fever release pain stop and anti-inflammation |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN1053810C (en) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN100344288C (en) * | 2002-12-16 | 2007-10-24 | 李广义 | Compound pain-stopping and inflammation-diminishing anticarcinogen capsule |
| CN103945483B (en) * | 2014-02-25 | 2017-05-24 | 重庆邮电大学 | Opportunity-network full-coverage low-time-delay routing method based on message ferry |
| CN104935664B (en) * | 2015-06-19 | 2018-12-21 | 中国铁道科学研究院集团有限公司电子计算技术研究所 | Seat automatic load balancing method and system |
-
1994
- 1994-04-27 CN CN94104518A patent/CN1053810C/en not_active Expired - Fee Related
Non-Patent Citations (1)
| Title |
|---|
| 新编药物学 1996.3.31 陈新谦，金有豫，人民卫生出版社 * |
Also Published As
| Publication number | Publication date |
|---|---|
| CN1110914A (en) | 1995-11-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN101780229B (en) | Traditional Chinese medicine composition for treating gum bleeding and preparation method thereof | |
| DE69633721D1 (en) | ADMINISTRATION OF MEDICINAL PRODUCTS IN THE LOWER DIGESTIVE WAY | |
| CA2570474A1 (en) | A combination composition comprising paracetamol and ibuprofen | |
| CN102309723A (en) | Traditional Chinese medicine composition for treating arthralgia and preparation method of ointment thereof | |
| CN1053810C (en) | Compound capsule for fever release pain stop and anti-inflammation | |
| CN109453169B (en) | Application of bulleyaconitine A | |
| CN104740425A (en) | Pharmaceutical composition for treating rheumatic arthralgia, preparation method and application of pharmaceutical composition | |
| CN100396316C (en) | Chinese medicine capsule for treating protrusion of intervertebral disc and hyperosteogeny | |
| CN101194988A (en) | Powder medicament for treating mouth ulcer | |
| JPH0656677A (en) | Antacid composition | |
| CN1207039C (en) | Medicine for curing cerebral concussion and injuries from falls | |
| CN1173355A (en) | Recovering liquid for oral cavity ulcer | |
| CN101194994B (en) | Externally used medicament for treating toothache | |
| JPS59116219A (en) | Novel medicine mixture containing combination of central analgesic and vitamin b 12 or derivative as active component | |
| RU2245157C2 (en) | Biologically active additive for preventing and treating flu cases | |
| CN103623184B (en) | The Chinese medicine for the treatment of prolapse of lumbar intervertebral disc and manufacture method | |
| CN108066397A (en) | Pharmaceutical composition | |
| JP2000229853A (en) | Menstruation pain-improving composition | |
| CN102631421A (en) | Traditional Chinese medicine for treating senile dementia | |
| DE60121142T2 (en) | COMPOSITION COMPRISING PARACETAMOL AND NIFLUMIC ACID CONTENT | |
| Minichetti et al. | Hallucination and delirium reaction to intravenous diazepam administration: case report. | |
| CN1212148C (en) | External plaster of sea horse and soft-shelled turtle | |
| CN101433576A (en) | Children's antidiarrheal paste | |
| KR20240039395A (en) | Excipient composition for enhancing the effect of oriental medicine prescription drug and the method for manufacturing oriental medicine prescription drug using the same | |
| CN1134835A (en) | Pharmaceutics for treating tooth-ache |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| C19 | Lapse of patent right due to non-payment of the annual fee | ||
| CF01 | Termination of patent right due to non-payment of annual fee |